Risk Management Plans: Implementation of the New Pharmacovigilance Legislation in Mexico

被引：0
|
作者：
Duran, H. [1 ]
Alatorre, R. [2 ]
Lara, O. [1 ]
机构：
[1] COFEPRIS, RMP Coordinat, Mexico City, DF, Mexico
[2] COFEPRIS, CEMAR, Mexico City, DF, Mexico
来源：
DRUG SAFETY | 2018年 / 41卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
ISoP18-144
引用
收藏
页码：1244 / 1245
页数：2
相关论文
共 50 条
  • [1] Risk Management: Quality and Safety New EU legislation and implementation
    Coffey, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S337 - S338
  • [2] European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?
    Bleumink, GS
    Veld, BAI
    Stricker, BHC
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (04) : 339 - 340
  • [3] New Pharmacovigilance Legislation in the Eu
    Farzan, J.
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (06): : 267 - 269
  • [4] Experience of Implementation of Risk Management Plans in Argentina
    Santucci, C.
    Bignone, I.
    Heredia, R.
    Prokopez, C.
    Papale, R.
    DRUG SAFETY, 2014, 37 (10) : 879 - 880
  • [5] New EU pharmacovigilance legislation enacted
    Reactions Weekly, 2012, 1409 (1) : 2 - 2
  • [6] Evaluating the Effectiveness of Risk Minimisation Measures in the Context of the New Pharmacovigilance Legislation in the EU
    Rubino, Annalisa
    Straus, Sabine
    Auclert, Laurent
    Zografos, Laurie J.
    Andrews, Elizabeth B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 195 - 196
  • [7] Analysis of the ADRs of Medication Error in EudraVigilance: Impact of the Implementation of the New European Union Pharmacovigilance Legislation
    Cuconato, V.
    Cicalese, M. C.
    Casini, M. L.
    Minore, C.
    Ruggieri, S.
    Di Girolamo, M.
    DRUG SAFETY, 2013, 36 (09) : 899 - 900
  • [8] Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016-2019
    Kohama, Mei
    Nonaka, Takahiro
    Uyama, Yoshiaki
    Ishiguro, Chieko
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (01) : 37 - 47
  • [9] Correction: Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016–2019
    Mei Kohama
    Takahiro Nonaka
    Yoshiaki Uyama
    Chieko Ishiguro
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 48 - 48
  • [10] The new pharmacovigilance legislation and impact on observational studies
    Gulmez, Sinem Ezgi
    MARMARA PHARMACEUTICAL JOURNAL, 2013, 17 (02) : 61 - 64
12345